Recently there have been successful advances for the treatment of Parkinson’s Disease. Volunteers with PD have paved the way for better treatments through clinical trials. Learn about new treatments that are now FDA approved.
Nuplazid™ – The first and only FDA-approved therapy for hallucinations and delusions associated with psychosis in Parkinson’s Disease. Nuplazid™ (also known by the generic name pimavanserin) works by blocking some of the effects of the neurotransmitter serotonin for which one of the specific receptors is expressed excessively especially in certain brain areas important in processing [...]